title: Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.
authors.affiliation: Metabolism Unit, CNR Institute of Clinical Physiology, Pisa, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Santoro
authors.forename: A
authors.initials: A
authors.lastname: Natali
authors.forename: A Q
authors.initials: AQ
authors.lastname: Galvan
authors.forename: A
authors.initials: A
authors.lastname: Masoni
authors.forename: P
authors.initials: P
authors.lastname: Gazzetti
authors.forename: E
authors.initials: E
authors.lastname: Ferrannini
mesh_terms: D000450:Aldosterone / Q000097:blood; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001786:Blood Glucose / Q000032:analysis; D017315:Cilazapril; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000627:therapeutic use*; D016037:Single-Blind Method
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose; D007328:Insulin; D011724:Pyridazines; D017315:Cilazapril; D000450:Aldosterone